The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial. Br J Haematol. 2016 Apr; 173(1):96-104.
-
Robert Jon Soiffer, M.D.
-
Angela Ann Giardino, M.D., M.D.
-
Corey Stephen Cutler, M.D.
-
Philippe Armand, M.D.,Ph.D.
-
Haesook Teresa Kim, Ph.D.
-
Joseph Harry Antin, M.D.
-
Steven Lawrence McAfee, M.D.
-
Vincent T. Ho, M.D.
-
John Koreth, M.B.,B.S.